highlights in bladder canceres: keynote-045 keynote-052 dr. fabio schutz
Published 7 years ago • 148 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
4:54
kidney cancer highlights - dr. fabio schutz
-
1:19
dr. bellmunt shares keynote-045 data for pembrolizumab versus chemotherapy in bladder cancer
-
0:51
impact of the keynote-045 study comparing pembrolizumab and chemotherapy in bladder cancer
-
6:32
highlights in bladder cancer from esmo 2022
-
1:56
dr. fabio schutz
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
2:27
dr. fabio schutz
-
59:04
2022 ask the bladder cancer experts
-
1:01:23
2023 ask the bladder cancer experts
-
14:04
bladder cancer - 6 - chemo summary
-
6:03
queensland bladder cancer initiative - qbci – improving outcomes in bladder cancer
-
1:54
highlights in bladder cancer at esmo 2022
-
8:04
bladder cancer highlights: clinical implications
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
2:30
highlights from world bladder cancer patient forum 2022
-
0:57
dr. petrylak on the keynote-045 trial for urothelial carcinoma
-
31:19
new and emerging therapeutic strategies in bladder cancer
-
1:47
the future of bladder cancer | johns hopkins greenberg bladder cancer institute
-
31:06
bladder cancer | 2022 oneoncology conference
-
1:45
dr. rosenberg on the keynote-045 trial in advanced urothelial cancer
-
6:17
interview with dr. balar
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer